Regulation of low-density lipoprotein particle size distribution in NIDDM and coronary disease: Importance of serum triglycerides

Diabetologia

Volumn 39, Issue 4, 1996, Pages 453-461

  Lahdenpera S ^a   Syvanne M ^a   Kahri, J ^a   Taskinen, M R ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Coronary artery disease; Electrophoresis; LDL composition; Non insulin dependent diabetes mellitus; Small dense LDL

Indexed keywords

LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; HUMAN; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

ANALYSIS OF VARIANCE; CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; GLYCOPROTEINS; HUMANS; LIPASE; LIPOPROTEIN LIPASE; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; LIVER; MALE; MIDDLE AGED; REFERENCE VALUES; RISK FACTORS; TRIGLYCERIDES;

EID: 0029935166     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050465     Document Type: Article

References (56)

1. Kannel WB, McGee DL (1979) Diabetes and cardiovascular disease: the Framingham Study. JAMA 241: 2035-2038
2. Nathan DM (1993) Long-term complications of diabetes mellitus. N Engl J Med 328: 1676-1685
3. Wingard DL, Barrett-Connor E, Criqui MH, Suarez L (1983) Clustering of heart disease risk factors in diabetic compared to nondiabetic adults. Am J Epidemiol 117: 19-26
4. Pyörälä K, Laakso M, Uusitupa M (1987) Diabetes and atherosclerosis: an epidemiological view. Diabetes Metab Rev 3: 463-524
5. Stamler J, Vaccaro O, Neaton JD, Wenthworth D (1993) Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 16: 434-444
6. Howard BJ (1987) Lipoprotein metabolism in diabetes mellitus. J Lipid Res 28: 613-628
7. Taskinen M-R (1990) Hyperlipidemia in diabetes. Clin Endocrinol Metab 4: 743-775
8. Taskinen M-R (1992) Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus. Diabetes 41 [Suppl 2]: 12-17
9. Pfeiffer MA, Brunzell JD, Best JD, Judgewitsch RG, Halter JB, Porte D Jr (1983) The response of plasma triglyceride, cholesterol, and lipoprotein lipase to treatment in non-insulin-dependent diabetic subjects without familial hypertriglyceridemia. Diabetes 32: 525-531
10. Fontbonne A, Eschwege E, Cambien F et al. (1989) Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study. Diabetologia 32: 300-304
11. Laakso M, Lehto S, Penttilä I, Pyörälä K (1993) Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes. Circulation 88 [Part 1]: 1421-1430
12. Fisher WJ (1983) Heterogeneity of plasma low density lipoproteins; manifestations of the physiologic phenomenon in man. Metabolism 32: 283-291
13. Krauss RM, Burke DJ (1982) Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res 23: 97-104
14. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM (1988) Low density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 260: 1917-1921
15. Austin MA, King MC, Vranizan KM, Krauss RM (1990) Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation 82: 495-506
16. Campos H, Blijlevens E, McNamara JR et al. (1992) LDL particle size distribution. Results from the Framingham offspring study. Arterioscler Thromb 12: 1410-1419
17. Barrett-Connor E, Grundy SM, Holdbrook MJ (1982) Plasma lipids and diabetes mellitus in an adult community. Am J Epidemiol 115: 657-663
18. Rönnemaa T, Laakso M, Kallio V, Pyörälä K, Marniemi J, Puukka P (1989) Serum lipids, lipoproteins, and apolipoproteins and the excessive occurrence of coronary heart disease in non-insulin-dependent diabetic patients. Am J Epidemiol 130: 632-645
19. Uusitupa MIJ, Niskanen LK, Siitonen O, Voutilainen E, Pyörälä K (1993) Ten-year cardiovasular mortality in relation to risk factor and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia 36: 1175-1184
20. Tilly-Kiesi M, Syvänne M, Kuusi T, Lahdenperä S, Taskinen M-R (1992) Abnormalities of low-density lipoproteins in normolipidemic type 2 diabetic and non-diabetic patients with coronary heart disease. J Lipid Res 33: 333-342
21. Deckelbaum RJ, Granot E, Oschry Y, Rose L, Eisenberg S (1984) Plasma triglyceride determines structure-composition in low and high density lipoproteins. Arteriosclerosis 4: 225-231
22. Barakat HA, Carpenter JW, McLendon VD et al. (1990) Influence of obesity, impaired glucose tolerance, and NIDDM on LDL structure and composition: possible link between hyperinsulinemia and atherosclerosis. Diabetes 39: 1527-1533
23. Coresh J, Kwiterovich PO, Smith HH, Bachorik PS (1993) Association of plasma triglyceride concentration and LDL particle diameter, density, and chemical composition with premature coronary artery disease in men and women. J Lipid Res 34: 1687-1697
24. McNamara JR, Campos H, Ordovas JM, Peterson J, Wilson PWF, Schaefer EJ (1987) Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution. Results from the Framingham offspring study. Arteriosclerosis 7: 483-490
25. Syvänne M, Kahri J, Virtanen KS, Taskinen M-R (1995) High density lipoproteins containing apolipoproteins A-I and A-II (LpA-I:A-II) as markers of coronary artery disease in men with non-insulin-dependent diabetes mellitus. Circulation (in press)
26. World Health Organization (1980) WHO Expert Committee on Diabetes Mellitus, Second Report. Geneva, World Health Organization, (Techn. Rep. Ser., no.646)
27. Kupari M, Virtanen KS, Turto H et al. (1992) Exclusion of coronary artery disease by exercise thallium-201 tomography in patients with aortic valve stenosis. Am J Cardiol 70: 635-640
28. Havel JR, Eder HA, Bragdon JH (1955) Distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34: 1345-1353
29. Taskinen M-R, Kuusi T, Helve E, Nikkilä E, Yki-Järvinen H (1988) Insulin therapy induces antiatherogenic changes of serum lipoproteins in non-insulin-dependent diabetes. Arteriosclerosis 8: 168-177
30. Nichols AV, Krauss RM, Musliner TA (1986) Nondenaturing polyacrylamide gel electrophoresis. In: Segrest JP, Albers JJ (eds). Methods in enzymology: plasma lipoproteins. Vol. 128. Academic Press London, p.417
31. Lahdenperä S, Tilly-Kiesi M, Vuorinen-Markkola H, Kuusi T, Taskinen M-R (1993) Effects of gemfibrozil on low-density lipoprotein particle size, density distribution, and composition in patients with type II diabetes. Diabetes Care 16: 584-592
32. Huttunen JK, Ehnholm C, Kinnunen PJ, Nikkilä EA (1975) An immunochemical method for measurement of two triglyceride lipases in human postheparin plasma. Clin Chim Acta 63: 335-347
33. Groener JEM, Pelton RW, Kostner GM (1986) Improved estimation of cholesteryl ester transfer activities. Clin Chem 32: 283-286
34. Kahri J, Syvänne M, Taskinen M-R (1994) Plasma cholesteryl ester transfer protein activity in NIDDM patients with and without coronary artery disease. Metabolism 43: 1498-1502
35. Kashyap MR, Hynd BA, Robinson K (1980) A rapid and simple method for measurement of total protein in very low density lipoprotein by the Lowry assay. J Lip Res 21: 491-495
36. Syvänne M, Ahola M, Lahdenperä S et al. (1995) High density lipoprotein subfractions in non-insulin-dependent diabetes mellitus and coronary artery disease. J Lip Res 36: 573-582
37. Feingold KR, Grunfeld C, Coerrler W, Krauss RM (1992) LDL subclass phenotypes and triglyceride metabolism in non-insulin-dependent diabetes. Arterioscler Thromb 12: 1496-1502
38. Haffner SM, Mykkänen L, Stern MP, Paidi M, Howard BV (1994) Greater effect of diabetes on LDL size in women than in men. Diabetes Care 17: 1164-1171
39. Griffin BA, Freeman DJ, Tait GW et al. (1994) Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart risk. Atherosclerosis 106: 241-253
40. Pometta D, James RW (1993) Factors affecting lipoprotein in diabetes. International symposium on the lipid triad (triglycerides, HDL, LDL) and cardiovascular diseases. Milan, Italy July 5-8, 1993 (Abstract)
41. American Diabetes Association (1993) Detection and management of lipid disorders in diabetes. Diabetes Care 16: 828-834
42. NIH Consensus Development Panel (1993) Triglyceride, high-density lipoprotein, and coronary heart disease. JAMA 269: 505-510
43. Manzato E, Zambon S, Zambon A, Cortella A, Sartore G, Grepaldi G (1993) Levels and physiochemical properties of lipoprotein subclasses in moderate hypertriglyceridemia. Clin Chem Acta 219: 57-65
44. Cohen JC, Grundy SM (1993) Normal postprandial lipemia in men with low plasma HDL concentrations. Arterioscler Thromb 12: 972-975
45. Taskinen M-R, Packard CJ, Shepherd J (1990) Effect of insulin therapy on metabolic fate of apolipoprotein B-containing lipoproteins in NIDDM. Diabetes 39: 1017-1027
46. Packard CJ, Gaw A, Demant T, Shepherd J (1995) Development and application of a multicompartmental model to study very low density lipoprotein subfraction metabolism. J Lipid Res 36: 172-187
47. Nigon F, Lesnik P, Rouis M, Chapman MJ (1991) Discrete subspecies of human low density lipoproteins are heterogeneous in their interaction with the cellular LDL receptor. J Lipid Res 32: 1741-1753
48. Lagrost L, Gambert P, Lallemant C (1994) Combined effects of lipid transfers and lipolysis on gradient gel patterns of human plasma LDL. Arterioscler Thromb 14: 1327-1336
49. Taskinen M-R (1995) Insulin resistance and lipoprotein metabolism. Current Opinion in Lipidology 6: 153-160
50. McKeone BJ, Patsch JR, Pownall HJ (1993) Plasma triglycerides determine low density lipoprotein composition, physical properties, and cell-specific binding in cultured cells. J Clin Invest 91: 1926-1933
51. Chait A, Brazg RL, Tribble DL, Krauss RM (1993) Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B. Am J Med 94: 350-356
52. Galeano NF, Milne R, Marcel YL et al. (1994) Apoprotein B structure and receptor recognition of triglyceride-rich low density lipoprotein (LDL) is modified in small LDL but not in triglyceride-rich LDL of normal size. J Biol Chem 269: 511-519
53. Fielding CJ, Reaven GM, Liu G, Fielding PE (1984) Increased free cholesterol in plasma low and very low density lipoproteins in non-insulin-dependent diabetes mellitus: its role in the inhibition of cholesteryl ester transfer. Proc Natl Acad Sci 81: 2512-2516
54. Owens D, Maher V, Collins P, Johnson A, Tomkin GH (1990) Cellular cholesterol regulation - a defect in the type 2 (non-insulin-dependent) diabetic patient in poor metabolic control. Diabetologia 33: 93-99
55. Kuksis A, Myher JJ, Geher K et al. (1982) Decreased plasma phosphatidylcholine/free cholesterol ratio as an indicator of risk for ischemic vascular disease. Arteriosclerosis 2: 296-302
56. Vakakis N, Redgrave TG, Small DM, Castelli WP (1983) Cholesterol content of red blood cells and low density lipoproteins in hypertriglyceridemia. Biochim Biophys Acta 751: 280-285